AstraZeneca PLC Sponsored ADRAstraZeneca PLC Sponsored ADRAstraZeneca PLC Sponsored ADR

AstraZeneca PLC Sponsored ADR

No trades
See on Supercharts

Key facts today


AstraZeneca reported positive results for its bispecific antibody rilvegostomig at ESMO 2025, showing good tolerability and efficacy in Phase 2 trials for non-small cell lung and bladder cancers.
AstraZeneca (AZN) closed at 1,642.00 SEK, up 28.00 SEK (1.73%), and at 13,126.00 pence in the UK, rising 226.00 pence (1.75%) in recent trading.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪263.12 B‬USD
3.04USD
‪7.04 B‬USD
‪54.10 B‬USD
‪3.10 B‬
Beta (1Y)
0.35

About AstraZeneca PLC


CEO
Pascal Soriot
Headquarters
Cambridge
Founded
1913
ISIN
US0463531089
FIGI
BBG000BZ0DK8
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US46353AL2
AstraZeneca PLC 3.375% 16-NOV-2025
Yield to maturity
9.06%
Maturity date
Nov 16, 2025
US46353AZ1
AstraZeneca PLC 3.0% 28-MAY-2051
Yield to maturity
5.33%
Maturity date
May 28, 2051
US46353AX6
AstraZeneca PLC 2.125% 06-AUG-2050
Yield to maturity
5.31%
Maturity date
Aug 6, 2050
US46353AU2
AstraZeneca PLC 4.375% 17-AUG-2048
Yield to maturity
5.29%
Maturity date
Aug 17, 2048
US46353AM0
AstraZeneca PLC 4.375% 16-NOV-2045
Yield to maturity
5.29%
Maturity date
Nov 16, 2045
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.15%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.85%
Maturity date
Sep 15, 2037
A
US4636NAN3
AstraZeneca Finance LLC 5.0% 26-FEB-2034
Yield to maturity
4.55%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.33%
Maturity date
Mar 3, 2033
A
US4636NAA1
AstraZeneca Finance LLC 1.2% 28-MAY-2026
Yield to maturity
4.31%
Maturity date
May 28, 2026
50UC
AstraZeneca PLC 5.75% 13-NOV-2031
Yield to maturity
4.26%
Maturity date
Nov 13, 2031

See all AZN bonds 

QQQ
Invesco QQQ Trust Series I
Weight
0.26%
Market value
‪1.05 B‬
USD
QQQM
Invesco NASDAQ 100 ETF
Weight
0.26%
Market value
‪177.33 M‬
USD
PVAL
Putnam Focused Large Cap Value ETF
Weight
1.78%
Market value
‪81.55 M‬
USD
HHL
Harvest Healthcare Leaders Income ETF
Weight
5.05%
Market value
‪62.16 M‬
USD
HHL.U
Harvest Healthcare Leaders Income ETF
Weight
5.05%
Market value
‪62.16 M‬
USD
NQSE
iShares NASDAQ 100 UCITS ETF
Weight
0.26%
Market value
‪61.82 M‬
USD
CNDX
iShares NASDAQ 100 UCITS ETF USD
Weight
0.26%
Market value
‪61.82 M‬
USD
CGGO
Capital Group Global Growth Equity ETF
Weight
0.76%
Market value
‪58.16 M‬
USD
DIHP
Dimensional International High Profitability ETF
Weight
1.05%
Market value
‪49.35 M‬
USD
DFIC
Dimensional International Core Equity 2 ETF
Weight
0.45%
Market value
‪48.77 M‬
USD

Explore more ETFs